Form D · Biotechnology

Pattern Bioscience, Inc.

Austin, TX · CIK 0001735812

Offering snapshot reported Aug 18, 2025 · SEC filing

Reported sold
$44.2M
Offering amount: $61.2M
Investors reported
6
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Jul 31, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 18, 2025Initial$44,221,343No comparison6SEC filing
Jan 12, 2023Initial$23,499,993No comparison4SEC filing
Jul 10, 2020Initial$6,000,001No comparison1SEC filing
Oct 23, 2019Amendment$6,420,008$920,009vs Sep 11, 201913SEC filing
Sep 11, 2019Initial$5,499,999No comparison2SEC filing
Apr 3, 2018Initial$3,550,000No comparison10SEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
$0
Finders' fees
$0
Form D file number
021-555024

Source: Form D, filed Aug 18, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Nicolas Arab Director, Executive
Patrick Balthrop Director
Patrick J. Balthrop, Sr. Director
Carey Ann Burnham Director, Executive
Bryan Gammon Director
Junjun Gao Director
Ross Johnson Executive, Promoter
Oscar Marx Director
Oscar B. Marx Iii Director
Scott Mendel Director
Nicholas Naclerio Director
Johnson Ross Executive
Greg Wood Director
Gregory Wood Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
9600 Great Hills Tr Suite 160 E
Austin, TX, 78759